Marker Therapeutics, Inc. (MRKR) SEC Filings — 2025
19 SEC filings for Marker Therapeutics, Inc. (MRKR) in 2025.
Filings
- Marker Therapeutics, Inc. 8-K Filing — 8-K · Nov 14, 2025
- Marker Therapeutics' Losses Widen Amid R&D Spend, Cash Runway Shortens — 10-Q · Nov 13, 2025
- Marker Therapeutics Files 8-K on Director Changes and Compensation — 8-K · Nov 5, 2025
- Marker Therapeutics Files 8-K — 8-K · Oct 6, 2025
- Marker Therapeutics Files 8-K — 8-K · Aug 26, 2025
- Marker Therapeutics' Losses Mount Amid R&D Surge, Cash Dwindles — 10-Q · Aug 14, 2025
- Marker Therapeutics to be Acquired by 03 Life Sciences — 8-K · Aug 12, 2025
- Marker Therapeutics Files 8-K — 8-K · Jun 17, 2025
- Marker Therapeutics Files 8-K on Shareholder Votes & Financials — 8-K · Jun 9, 2025
- Marker Therapeutics Files 8-K — 8-K · May 20, 2025
- Marker Therapeutics 10-Q: Equity Offering & Financial Update — 10-Q · May 15, 2025
- Marker Therapeutics Proxy Statement Filed for June 6 Meeting — DEF 14A · Apr 24, 2025
- Marker Therapeutics Files 8-K on Financials — 8-K · Mar 31, 2025
- Marker Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025
- Marker Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Mar 27, 2025
- Marker Therapeutics Files 8-K/A: CMO Departure, New Interim CMO — 8-K/A · Mar 4, 2025
- Marker Therapeutics Appoints New CMO, Adopts Equity Plan — 8-K · Feb 19, 2025
- Marker Therapeutics Files Definitive Proxy Statement — DEF 14A · Feb 4, 2025
- Marker Therapeutics Announces CMO Departure, Executive Compensation Details — 8-K · Jan 30, 2025